Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Colombiana de Cardiología
versión impresa ISSN 0120-5633
Resumen
HURTADO-MARTINEZ, Laura; SALDARRIAGA-GIRALDO, Clara I.; JARAMILLO-JARAMILLO, Laura I. y HORMAZA-ANGEL, María P.. Cardiovascular risk during menopause: gynecologist and cardiologist view. Rev. Colomb. Cardiol. [online]. 2022, vol.29, n.1, pp.7-15. Epub 22-Feb-2022. ISSN 0120-5633. https://doi.org/10.24875/rccar.21000101.
Cardiovascular disease continues to be the main cause of death in the world. Women present a protective factor against it during the reproductive age due to the effect of estrogens on the vascular endothelium typical of this stage of life; later, perimenopause and post-menopause give rise to hypoestrogenemia states that generate an increased risk of cardiovascular disease and death from this cause. Hormone replacement therapy is a fundamental pillar for the treatment of vasomotor symptoms in menopause, it also has a positive impact on other outcomes such as cardiovascular risk, bone protection, depression, among other pathologies. We present a compendium of concepts regarding menopause and cardiovascular risk; historical aspects and treatment measures based on hormone replacement therapy.
Palabras clave : Menopause; Estrogens; Cardiovascular diseases.